Home/Filings/4/0000899243-21-024974
4//SEC Filing

Brown Willie L. Jr. 4

Accession 0000899243-21-024974

CIK 0001629137other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:18 PM ET

Size

17.1 KB

Accession

0000899243-21-024974

Insider Transaction Report

Form 4
Period: 2021-06-17
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2021-06-173,0370 total
    From: 2021-06-17Common Stock (3,037 underlying)
  • Exercise/Conversion

    Common Stock

    2021-06-17+3,03739,265 total
  • Award

    Stock Option (Right to Buy)

    2021-06-17+5,6005,600 total
    Exercise: $37.09Exp: 2031-06-16Common Stock (5,600 underlying)
  • Award

    Restricted Stock Units

    2021-06-17+3,6003,600 total
    Common Stock (3,600 underlying)
Footnotes (4)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vested in a single installment on June 17, 2021.
  • [F3]The shares subject to this option shall vest and become exercisable in equal monthly installments over a period of 12 months following June 17, 2021 for 11 months and the remaining 1/12th on the earlier of (i) June 17, 2022 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
  • [F4]The shares of Common Stock underlying the RSUs vest in a single installment on the earlier of (i) June 17, 2022 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeother

Related Parties

1
  • filerCIK 0001650411

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:18 PM ET
Size
17.1 KB